Insulin Resistance Clinical Trial
Official title:
The Effect of 12-week Circuit Training (Combination of Strength and Endurance Exercises) on Insulin Sensitivity and Vascular Endothelial Function in Women With Insulin Resistance
Verified date | May 2024 |
Source | Poznan University of Physical Education |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
During the last 10 years many studies concerning the impact of physical training on whole-body insulin sensitivity have been published, but there is a lack of an extended investigation on the potential clinical benefits of novel circuit training-based on strength and endurance exercises-relating to the optimization of insulin sensitivity and vascular endothelial function. It is of interest to precisely determine the physiological and biochemical effects of circuit training. An important aspect of the planned research will be the analysis of the effects of physical training on the released during muscle contraction myokines capable of modulating various metabolic processes. We hypothesized that in studied participants 12 weeks of the novel form of training would result in improving insulin sensitivity and vascular endothelial function mainly via myokines released by contracting skeletal muscles. The following questions will be asked: (1) whether the 12-week circuit training (combined strength and endurance exercises) performed by women with insulin resistance, improves insulin sensitivity, carbohydrate and lipid metabolism and promotes the efficiency of endothelial defense mechanisms? (2) whether the 12-week circuit training (combined of strength and endurance exercises) changes the concentrations of transcription factors regulating lipid and carbohydrate metabolism or the synthesis and/or secretion of myokines and adipokines in women with insulin resistance? (3) whether the 12-week strength training, interspersed with bouts of endurance exercise has a positive effect on cytokine profile? (4) whether there is a relationship between changes in body composition, HOMA-IR, and the level of myokines caused by physical training? (5) whether the 12-week circuit training reduces low back pain symptoms, plantar stifness and improve functioning of the patient in everyday life? A group of 80 women, aged 25 to 45 years, with diagnosed insulin resistance will participate in the planned study. Participants will be enrolled in the research program based on medical qualification. Before the intervention all women will have venous blood collected to determine fasting glucose, hemoglobin glycosylated (HbA1C) and insulin levels and insulin resistance by the homeostasis model assessment of insulin resistance (HOMA-IR) will be calculated. The inclusion criteria will be as follows: (1) women, age: 25-45 years, menstruating, (2) BMI 18,5-29,9 kg/m2, (3) insulin resistance based on HOMA-IR (cut-off point 2.5), (4) HbA1C ≤ 6.5%, (5) not contraindicated to physical activity. Participants meeting the inclusion criteria will be randomly divided into two groups. The first group of women will undergo circuit training, consisting of exercises performed on 7 machines arranged in a circuit. Thanks to the use of adequate software the machines will automatically adjust their parameters, such as seat height or resistance to the exercising person, and the training progress will be individually monitored. The planned training will last for 3 months, during which the patients will exercise 3 times a week for 30 minutes (2 circuits will be done during each session). The planned duration of the training session will be controlled (one minute for strength exercises, four minutes for endurance exercises and a 30-second break between each exercise). In the training group, one-repetition maximum exercise test (1RM) will be performed to determine the appropriate training load and later after the program to verify the increase in muscle strength. The range of maximum heart rate (HRmax) will also be determined in all exercising women. The second group of women, who will be asked to maintain their current level of physical activity and their diet for a period of 3 months will serve as a control group. Before and after the training program in all participants of the study pulse wave velocity, anthropometric parameters and body composition will be assessed. Concurrently venous blood will be taken to determine biochemical indicators related to carbohydrate and lipid metabolism, insulin resistance, vascular endothelium function, inflammation and adipocytokines and myokines. In both groups of women, the questioners concerning dietary intake and the level of daily physical activity will be administered. Results will be subjected to analysis involving descriptive, and advanced statistic method among them analysis of correlations, regression, variance and cluster analysis. All calculations and statistics will be performed using TIBCO Statistica 13.3 software (TIBCO).
Status | Active, not recruiting |
Enrollment | 49 |
Est. completion date | June 30, 2025 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 25 Years to 45 Years |
Eligibility | Inclusion Criteria: - women, - age: 25-45years, - menstruating, - BMI 18,5-29,9 kg/m2, - insulin resistance based on HOMA -IR (cut-off point 2.5), - not contraindicated to physical activity. Exclusion Criteria: - type 1 and 2 diabetes, - poorly controlled hypertension (mean SBP >140mmHg and/or mean DBP >90mmHg) over the last month and/or need to modify the pharmacological treatment, - obesity: BMI > 30 kg/m2, - lipid disorders requiring implementation of pharmacological treatment in the last 3 months before or during observation, - a positive history of ischemic heart disease, carotid atherosclerosis and / or lower limb atherosclerosis, - clinically significant arrhythmias or conduction disorders, - chronickidney disease, - clinically significant liver dysfunction, - acute or chronic, clinically manifest inflammatory process, - an acute infection in the last month, - cancer, - taking dietary supplements within a month before inclusion and during observation, - taking medication that could interfere with the results of the tests, - other conditions that may pose any risk to the patient during the observation. |
Country | Name | City | State |
---|---|---|---|
Poland | Poznan University of Physical Education | Poznan |
Lead Sponsor | Collaborator |
---|---|
Poznan University of Physical Education | Poznan University of Medical Sciences |
Poland,
Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med. 2017 Mar 1;2(1):e000143. doi: 10.1136/bmjsem-2016-000143. eCollection 2016. — View Citation
Lambers S, Van Laethem C, Van Acker K, Calders P. Influence of combined exercise training on indices of obesity, diabetes and cardiovascular risk in type 2 diabetes patients. Clin Rehabil. 2008 Jun;22(6):483-92. doi: 10.1177/0269215508084582. — View Citation
Oh KJ, Lee DS, Kim WK, Han BS, Lee SC, Bae KH. Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines. Int J Mol Sci. 2016 Dec 22;18(1):8. doi: 10.3390/ijms18010008. — View Citation
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018 Aug 31;17(1):122. doi: 10.1186/s12933-018-0762-4. — View Citation
Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011 Sep;96(9):2898-903. doi: 10.1210/jc.2011-0435. Epub 2011 Jul 21. Erratum In: J Clin Endocrinol Metab. 2012 Jun;97(6):2203. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Homeostasis model assessment of insulin resistance (HOMA-IR) | pre-intervention | ||
Primary | Homeostasis model assessment of insulin resistance (HOMA-IR) | 48 hours after the intervention | ||
Primary | HbA1C [mmol/mol] | ELISA | pre-intervention | |
Primary | HbA1C [mmol/mol] | ELISA | 48 hours after the intervention | |
Primary | Insuline [mU/ml] | Radioimmunoassay | pre-intervention | |
Primary | Insuline [mU/ml] | Radioimmunoassay | 48 hours after the intervention | |
Primary | Systolic and diastolic blood pressure [mmHg] | pre-intervention | ||
Primary | Systolic and diastolic blood pressure [mmHg] | 48 hours after the intervention | ||
Primary | Pulse wave velocity (PWV) [m/s] | PWV will be performed using the SphygmoCor Px (Atcor Medical Blood Pressure Analysis System, Sydney, Australia. | pre-intervention | |
Primary | Pulse wave velocity (PWV) [m/s] | PWV will be performed using the SphygmoCor Px (Atcor Medical Blood Pressure Analysis System, Sydney, Australia. | 48 hours after the intervention | |
Primary | Glucose, Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) [mmol/l] | Dimension Flex Reagent Cartridge | pre-intervention | |
Primary | Glucose, Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) [mmol/l] | Dimension Flex Reagent Cartridge | 48 hours after the intervention | |
Primary | Irisin, Visfatin, Retinol-binding protein 4 (RBP-4) [pg/ml] | ELISA | pre-intervention | |
Primary | Irisin, Visfatin, Retinol-binding protein 4 (RBP-4) [pg/ml] | ELISA | 48 hours after the intervention | |
Primary | Apelin [ng/ml] | ELISA | pre-intervention | |
Primary | Apelin [ng/ml] | ELISA | 48 hours after the intervention | |
Primary | C Reactive Protein (hsCRP) [mg/l] | ELISA | pre-intervention | |
Primary | C Reactive Protein (hsCRP) [mg/l] | ELISA | 48 hours after the intervention | |
Primary | Interleukin-6 (IL-6), Interleukin-10 (IL-10) [pg/ml] | ELISA | pre-intervention | |
Primary | Interleukin-6 (IL-6), Interleukin-10 (IL-10) [pg/ml] | ELISA | 48 hours after the intervention | |
Primary | Endothelial nitric oxide synthase (eNOS) [ng/ml] | ELISA | pre-intervention | |
Primary | Endothelial nitric oxide synthase (eNOS) [ng/ml] | ELISA | 48 hours after the intervention | |
Primary | Muscle strength [kg] | Test 1RM will be performed for following groups of muscles: abdominal muscles; back of the thigh (biceps femoris muscle and muscles adjacent to it); latissimus dorsi muscle, shoulder girdle muscles and upper chest; erector spinae and other muscles of a back; gluteal muscles, hip adductor and abductor muscles. | pre-intervention | |
Primary | Muscle strength [kg] | Test 1RM will be performed for following groups of muscles: abdominal muscles; back of the thigh (biceps femoris muscle and muscles adjacent to it); latissimus dorsi muscle, shoulder girdle muscles and upper chest; erector spinae and other muscles of a back; gluteal muscles, hip adductor and abductor muscles. | 48 hours after the intervention | |
Secondary | Plantar stiffness [N/m] | Biomechanical properties will be assessed with myotonometer device. | pre-intervention | |
Secondary | Plantar stiffness [N/m] | Biomechanical properties will be assessed with myotonometer device. | 48 hours after the intervention | |
Secondary | State of tension of erector spinae muscles [Hz] | Natural oscillation frequency [Hz], characterizing Tone or Tension will be assessed with myotonometer device. | pre-intervention | |
Secondary | State of tension of erector spinae muscles [Hz] | Natural oscillation frequency [Hz], characterizing Tone or Tension will be assessed with myotonometer device. | 48 hours after the intervention | |
Secondary | Low back pain intensity: questionnaire | Visual analogue scale (VAS) pain intensity questionare (reporting a score on a 10-point scale, the minimum (0) means no pain and the maximum (10) means a worst pain imaginable | pre-intervention | |
Secondary | Low back pain intensity: questionnaire | Visual analogue scale (VAS) pain intensity questionare (reporting a score on a 10-point scale, the minimum (0) means no pain and the maximum (10) means a worst pain imaginable | 48 hours after the intervention | |
Secondary | Disability caused by pain in the spine | Oswestry questionnaire. When completing the questionnaire, the subject answers questions concerning: pain intensity, independence, lifting objects, walking, sitting, standing, sleeping, social life, sexual activity and traveling. The answers to the questions help to classify how limited the functioning of the patient is while performing certain activities. Responses are graded from 0 to 5. The overall score is given on a 0-50 point scale, where the higher the score, the greater the disability. | pre-intervention | |
Secondary | Disability caused by pain in the spine | Oswestry questionnaire. When completing the questionnaire, the subject answers questions concerning: pain intensity, independence, lifting objects, walking, sitting, standing, sleeping, social life, sexual activity and traveling. The answers to the questions help to classify how limited the functioning of the patient is while performing certain activities. Responses are graded from 0 to 5. The overall score is given on a 0-50 point scale, where the higher the score, the greater the disability. | 48 hours after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03383822 -
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT04203238 -
Potato Research for Enhancing Metabolic Outcomes
|
N/A | |
Recruiting |
NCT03658564 -
Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance
|
N/A | |
Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03627104 -
Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A | |
Active, not recruiting |
NCT03288025 -
Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)
|
N/A | |
Completed |
NCT03809182 -
Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
|
Phase 4 | |
Completed |
NCT01809288 -
Identifying Risk for Diabetes and Heart Disease in Women
|
||
Completed |
NCT04642482 -
Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity
|
Phase 4 | |
Terminated |
NCT03278236 -
Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Not yet recruiting |
NCT05540249 -
Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG
|
N/A | |
Withdrawn |
NCT04741204 -
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
|
Phase 4 |